MAI Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

MAI Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-14,000	Closed	-$57K	–	983
2022 Q1	$57K	Hold	14,000	–	–	﹤0.01%	870
2021 Q4	$50K	Hold	14,000	–	–	﹤0.01%	878
2021 Q3	$51K	Sell	14,000 -13,400	-49%	-$54.2K	﹤0.01%	770
2021 Q2	$119K	Hold	27,400	–	–	﹤0.01%	721
2021 Q1	$113K	Buy	+27,400	New	+$119K	﹤0.01%	688

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MAI Capital Management's ATRS Position: Q2 2022 in Review

MAI Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 14,000 shares — an estimated $57K sold.

MAI Capital Management first reported a position in ATRS in Q1 2021 and held it in 5 quarters. The position peaked at $119K in Q2 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

MAI Capital Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
MAI Capital Management sold 14,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $57K.
MAI Capital Management first reported a position in Antares Pharma, Inc. in Q1 2021 and held it in 5 quarters.
MAI Capital Management's Antares Pharma, Inc. position peaked at $119K in Q2 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on MAI Capital Management's 13F filing for Q2 2022, filed 19 Jul 2022.